PhD, Agricultural Economics, Michigan State University
MA, Economics, Michigan State University, The Eli Broad Graduate School of Management
MS, Agricultural Economics, The Ohio State University
BS, Agricultural Economics, The Ohio State University
2014 to Present:
Special Advisor/Consultant, Family Health Center of Marshfield, Inc., Marshfield, WI
2004 to Present:
Director, Office for Health Services Research, Associate Research Scientist, Marshfield Clinic Research Institute, Marshfield
2000 to 2004:
Director, Center for Health Services Research, Marshfield Clinic Research Institute, Marshfield
1989 to 2000:
Senior Researcher/Policy Analyst, Center for Health Services Research, Marshfield Clinic Research Institute, Marshfield
1987 to 1989:
Associate and Economic Analyst, Frank & Associates, Health & Management Consultants, Wauwatosa
1983 to 1987:
Economic Consultant, Washington, Washington
1981 to 1983:
Agricultural Economist and Policy Analyst, Agricultural Cooperative Service, US Department of Agriculture
1975 to 1977:
Research Specialist, Department of Agricultural Economics, University of Wisconsin-Madison, Madison
American Agricultural Economic Association
American Economic Association
Association for Health Services Research
National Rural Health Association
Wisconsin Rural Health Association
Marion BW, Mueller WF, Cotterill RW, Geithman FE, Schmelzer JR. (1979). The profit and price performance of leading food chains. American Journal of Agricultural Economics. 61 :420-433.
Purschwitz MA, Lee BC, Schmelzer JR. (1990). Agricultural injury prevention: the need for greater cooperation and involvement. J Rural Health. 6(3):221-230.
Kindig DA, Schmelzer JR, Hong W. (1992 October). Age distribution and turnover of physicians in nonmetropolitan counties of the United States. Health Serv Res. 27(4):565-578.
Schmelzer JR. (1996). Antitrust insights for rural providers from Marshfield Clinic's experience. Rural Health FYI. 18(3)
Smith PN, Vidaillet HJ, Hayes JJ, Schmelzer JR. (1997). Radiofrequency ablation in the Medicare population. PACE. 20 :1213.
Smith PN, Vidaillet HJ, Sharma PP, Hayes JJ, Schmelzer JR. (2001 January). Catheter ablation in the elderly in the United States: use in the Medicare population from 1991 to 1998. Pacing Clin Electrophysiol. 24(1):66-69.
Hillman MA, Wilke RA, Yale SH, Vidaillet HJ, Caldwell MD, Glurich IE,...Burmester JK [including Berg RL, Schmelzer JR.] (2005 August). A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. Clin Med Res. 3(3):137-145.
Caldwell MD, Berg RL, Zhang KQi, Glurich IE, Schmelzer JR, Yale SH,...Burmester JK [including Vidaillet HJ.] (2007 March). Evaluation of genetic factors for warfarin dose prediction. Clin Med Res. 5(1):8-16.
Schmelzer JR, Berg RL, Burmester JK, Yale SH, Caldwell MD. (2009 March). Is cost-effective genotype-informed warfarin dosing closer than we think? Ann Intern Med. [www.annals.org]
Yale SH, Schmelzer JR. (2009 September). Asthma Guidelines: The Product of Science and Politics. ANNALS OF FAMILY MEDICINE.
Burmester JK, Berg RL, Yale SH, Rottscheit CM, Glurich IE, Schmelzer JR, Caldwell MD. (2011 June). A randomized controlled trial of genotype-based Coumadin initiation. Genet Med. 13(6):509-18.
Godar DA, Kumar DR, Schmelzer KM, Talsness SR, Liang H, Schmelzer JR,...Yale SH [including Mazza JJ.] (2011 February). The impact of serum glucose on clinical outcomes in patients hospitalized with community-acquired pneumonia. WMJ. 110(1):14-20.
Pawloski P, Hedblom B, Hitz P, Owens B, Anderson C, McCarty CA,...Schmelzer JR [including Yale SH.] (2011 November). PS1-31: Assessing the Potential for Research on Genetics of Drug Induced Liver Injury in the HMORN Clinical Medicine & Research. 9(3-4):180.
Hemmes M, Arterburn DE, Gerhard G, McCarty CA, Nakasato C, Pawloski P,...Davis R [including Schmelzer JR, Yale SH.] (2011 November). PS1-18: A Feasibility Pilot to Determine the Practicality of Using the HMO Research Network to Research the Genetics of Drug-Induced Serious Adverse Events Clinical Medicine & Research. 9(3-4):180-1.
Burmester JK, Berg RL, Glurich IE, Yale SH, Schmelzer JR, Caldwell MD. (2011 November). Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses. Clinical Medicine & Research. 9(3-4):119-24.
Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF,...Mazza, JJ [including Caldwell MD, Schmelzer, J.] (2013 December 12). A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 369(24):2283-93.
Burns ME, Dague L, DeLeire T, Dorsch M, Friedsam D, Leininger LJ,...Voskuil K [including Schmelzer J.] (2014 December). The effects of expanding public insurance to rural low-income childless adults. Health Serv Res. 49 Suppl 2 :2173-87.
Leonhard LG, Berg RL, Burmester JK, Mazza JJ, Schmelzer JR, Yale SH. (2015 March). Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures. Clinical Medicine & Research. 13(1):1-6.
Burmester JK, Berg RL, Schmelzer JR, Mazza JJ, Yale SH. (2015 February). Factors that affect rate of INR decline after warfarin discontinuation. WMJ. 114(1):16-20.
Fang MC, Fan D, Sung SH, Witt DM, Yale SH, Steinhubl SR,...Schmelzer, John. (2015 June). Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study. JAMA Intern Med. 175(6):1060-2.
Bell LN, Berg RL, Schmelzer JR, Liang H, Mazza JJ, Kanth R,...Yale SH. (2017 January). Thromboembolic complications following a first isolated episode of superficial vein thrombosis: a cross-sectional retrospective study. J. Thromb. Thrombolysis. 43(1):31-37.